Ruihan Wang

Dr. Ruihan Wang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2023 in Separation and Purification Technology
Verified
Journal Article
Closed access
SGShu-Qi Gang
Shu-Qi Gang
ZLZi-Yue Liu
Zi-Yue Liu
YBYe-Nan Bian
Ye-Nan Bian
RWRuihan Wang
Ruihan Wang
JDJian-Long Du
Jian-Long Du

10 August 2023 in Frontiers in Neurology
Verified
Journal Article
Open access
HCHanlin Cai
Hanlin Cai
FYFeng Yang
Feng Yang
HGHui Gao
Hui Gao
KHKeru Huang
Keru Huang
LQLinyuan Qin
Linyuan Qin
QCQin Chen
Qin Chen
Objective: Idiopathic normal-pressure hydrocephalus (iNPH) is a treatable cause of dementia; however, its etiology and pathogenesis remain poorly understood. The objective of this study was to investigate the prevalence and impact of vascular risk factors in patients with iNPH compared to a control cohort to better understand the potential mechanisms and preventive measures.Methods: We systematically searched PubMed, Web of Science, Embase, and the Cochrane Library (from inception to December 20, 2022) for studies reporting vascular risk factors for the development of iNPH. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using random-effects models.Results: After screening 1,462 articles, 11 case-control studies comprising 1,048 patients with iNPH and 79,668 cognitively unimpaired controls were included in the meta-analysis. Our data showed that hypertension (N = 991, OR = 2.30, 95% CI 1.64 to 3.23, I2= 64.0%), diabetes mellitus (DM) (N = 985, OR = 3.12, 95% CI 2.29 to 4.27, I2= 44.0%), coronary heart disease (CHD; N = 880, OR = 2.34, 95% CI 1.33 to 4.12, I2= 83.1%), and peripheral vascular disease (N = 172, OR = 2.77, 95% CI 1.50 to 5.13, I2= 0.0%) increased the risk for iNPH, while overweight was a possible factor (N = 225, OR = 2.01, 95% CI 1.34 to 3.04, I2= 0.0%) based on the sensitivity analysis. Smoking and alcohol consumption were not associated with iNPH.Conclusions: Our study suggested that hypertension, DM, CHD, peripheral vascular disease, and overweight were associated with iNPH. These factors might be involved in the pathophysiological mechanisms promoting iNPH. These findings require further investigation in future studies.Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, CRD42022383004.

30 March 2024 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
SGShu-Qi Gang
Shu-Qi Gang
ZLZi-Yue Liu
Zi-Yue Liu
SWSu-Xia Wu
Su-Xia Wu
SYShu Yang
Shu Yang
RWRuihan Wang
Ruihan Wang
JDJian-Long Du
Jian-Long Du

10 April 2024 in Biomacromolecules
Verified
Journal Article
Closed access
BMBo Ma
Bo Ma
HCHedi Chen
Hedi Chen
JGJinyuan Gong
Jinyuan Gong
WLWenqiang Liu
Wenqiang Liu
XWXiuli Wei
Xiuli Wei
ZTZhongping Tan
Zhongping Tan

8 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SWSuxia Wu
Suxia Wu
CLChang Liu
Chang Liu
YLYang Li
Yang Li
XZXiaoyu Zhang
Xiaoyu Zhang
QHQianji Han
Qianji Han
SSShitao Song
Shitao Song
Amyloid-β (Aβ) aggregation is a central pathological hallmark of Alzheimer’s disease, with soluble trimers recognized as particularly neurotoxic species. Amentoflavone (AMF), a natural biflavonoid compound, has shown strong inhibitory effects on Aβ aggregation. However, its underlying molecular mechanism remains poorly understood. In this study, we employed replica exchange molecular dynamics (REMD) and molecular mechanics/Poisson–Boltzmann surface area (MM/PBSA) method to elucidate the interaction between AMF and Aβ peptides. Our results reveal that AMF preferentially binds to the 16KLVFFAEDV24 segment, a hydrophobic core that plays a critical role in the initiation of aggregation. It disrupts b-sheet formation through hydrophobic interactions with Leu-17, Phe-20, and Val-24. This binding stabilizes disordered coil conformations and prevents the conformational transitions required for fibril formation. Based on these findings, we performed structure-based virtual screening and identified two natural product-derived candidates with higher predicted affinity. These insights provide an atomic-level understanding of AMF’s inhibitory mechanism and support the rational design of natural product-inspired inhibitors that target Aβ aggregation.

20 June 2025 in Science Advances
Verified
Journal Article
Open access
YLYaohao Li
Yaohao Li
WLWenqiang Liu
Wenqiang Liu
RWRuihan Wang
Ruihan Wang
DLDan Liu
Dan Liu
XLXin Li
Xin Li
ZTZhongping Tan
Zhongping Tan
Protein and peptide aggregation poses substantial challenges in disease pathology and therapeutic development. While natural glycosylation may mitigate aggregation, its efficacy and underlying mechanisms remain poorly understood due to limited access to homogeneous samples with complex glycans. This study addresses these knowledge gaps by investigating the natural glycosylation of islet amyloid polypeptide (IAPP), a peptide with therapeutic potential for type 2 diabetes but problematic aggregation. An optimized chemical synthesis enabled preparation of diverse IAPP glycoforms with complex glycan structures, allowing systematic evaluation of their effects on aggregation, cytotoxicity, and solubility. Sialylated glycans at Thr 30 completely inhibited IAPP aggregation, eliminated cytotoxicity toward pancreatic β cells, and enhanced solubility by up to 280-fold. Replica exchange molecular dynamics simulations revealed that glycosylation impedes adoption of a four-stranded β-sheet conformation in IAPP dimers. These findings advance the understanding of the role of natural glycosylation in aggregation and highlight its potential as an evolutionarily inspired strategy to enhance the therapeutic utility of IAPP.